Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) saw some unusual options trading activity on Wednesday. Traders bought 1,885 put options on the company. This represents an increase of 1,101% compared to the average volume of 157 put options.
Evelo Biosciences Price Performance
Shares of EVLO remained flat at $0.00 during mid-day trading on Thursday. 10 shares of the stock traded hands, compared to its average volume of 3,032. Evelo Biosciences has a twelve month low of $0.00 and a twelve month high of $0.00. The firm has a market capitalization of $9,420.00, a P/E ratio of 0.00 and a beta of 0.47.
About Evelo Biosciences
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Featured Stories
- Five stocks we like better than Evelo Biosciences
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
